Dynamics of Progesterone, TNF-α, and a Metabolite of PGF2α in Blood Plasma of Beef Cows following Embryo Transfer

Abstract EN

Lactating beef cows previously synchronized for estrus (d 0) were assigned to four treatments to assess their effectiveness in increasing blood progesterone (P4) and its effects on tumor necrosis factor-α (TNF-α) and prostaglandin F2α (PGF2α) after the transfer of embryos.

At the time of transfer (d 7), cows received no treatment (control; n = 16 ), a controlled internal drug releasing device (CIDR; n = 16 ), human chorionic gonadotropin (hCG; n = 15 ), or gonadotropin releasing hormone (GnRH; n = 15 ).

Blood samples were taken on d 7, 14, and 21 for analysis of P4 and tumor necrosis factor-α (TNF-α).

Blood was collected (every 15 min for 2 h) in half the animals in each treatment group on d 14 and the remaining half on d 21 for analysis of prostaglandin F2α metabolite (PGFM).

Retention rates were 56.2, 62.5, 46.7, and 13.3% for cows in the control, CIDR, hCG, and GnRH groups, respectively.

Progesterone was greater ( P ≤ 0.05 ) in cows receiving hCG compared to others on d 14.

Progesterone in all treatment groups increased from d 7 to d 14 and declined ( P ≤ 0.05 ) from d 14 to d 21.

Contrary to pregnant cows, P4 and TNF-α declined from d 7 to d 21 in nonpregnant cows ( P ≤ 0.05 ).

Although PGFM increased by d 21, there was no difference between pregnant and nonpregnant cows.